View in EDS HTML Full Text PDF Full Text

Pitavastatin is a novel Mcl-1 inhibitor that overcomes paclitaxel resistance in triple-negative breast cancer.

Saved in:
Bibliographic Details
Title: Pitavastatin is a novel Mcl-1 inhibitor that overcomes paclitaxel resistance in triple-negative breast cancer.
Authors: Ko, Dongmi1,2 (AUTHOR), Park, Soeun1,2 (AUTHOR), Park, Minsu1,2 (AUTHOR), Kim, Seongjae1,2 (AUTHOR), Park, Jung Min1,2 (AUTHOR), Seo, Juyeon1,2 (AUTHOR), Nam, Kee Dal1,3 (AUTHOR), Kang, Yong Koo1,3 (AUTHOR), Farrand, Lee4 (AUTHOR), Jung, Eunsun1,2 (AUTHOR) silverline1209@gmail.com, Kim, Yoon-Jae1,2,3 (AUTHOR) natureyj@nate.com, Kim, Ji Young1,3 (AUTHOR) amaryllis1210@gmail.com, Seo, Jae Hong1,2,3 (AUTHOR) cancer@korea.ac.kr
Source: Experimental Hematology & Oncology. 10/22/2025, Vol. 14 Issue 1, p1-20. 20p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:21623619
DOI:10.1186/s40164-025-00716-6